Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Epicyte Pharmaceutical Inc.

Division of Biolex Therapeutics Inc.
www.epicyte.com

Latest From DermTech International

MiNDERA Corp.

MiNDERA Corp. is developing an alternative to punch biopsies for diagnosing skin cancer: its microneedle device extracts biomarkers from the skin in a procedure that the start-up says is highly accurate and cost-effective for office-based diagnostic applications in dermatology.

Medical Device

MiNDERA Corp.

MiNDERA Corp. is developing an alternative to punch biopsies for diagnosing skin cancer: its microneedle device extracts biomarkers from the skin in a procedure that the start-up says is highly accurate and cost-effective for office-based diagnostic applications in dermatology.

Medical Device

Medical Device Deals Update, June-July 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2014.

Medical Device Deals

Deals Shaping The Medical Industry, July/August 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Biolex Therapeutics Inc.
  • Senior Management
  • Lloyd M Kunimoto, CEO
    Christiane Sheid, CFO
    Andrew Hiatt, PhD, VP, Research
    Mich B Hein, PhD, Pres.
    Vincent Gotz, VP, Bus. Dev.
  • Contact Info
  • Epicyte Pharmaceutical Inc.
    Phone: (858) 554-0281
    5810 Nancy Ridge Dr., Ste. 150
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register